- ICH GCP
- Yhdysvaltain kliinisten tutkimusten rekisteri
- Kliininen tutkimus NCT01586039
Investigating the Effects of Evening Light Exposure on Melatonin Suppression, Alertness and Nocturnal Sleep
Investigating the Effects of Evening Light Exposure on Melatonin Suppression, Alertness and Nocturnal Sleep.
The timing and quality of sleep is governed by environmental and physiologic factors. Environmental factors, especially ambient lighting can impact the circadian system and alter the timing and structure of sleep. Light exposure can also acutely alter neural activation state and impair sleep. These effects all demonstrate marked sensitivity to short-wavelength blue light with maximal sensitivity in the 460-480 nm range. The alerting effects of blue light in the evening persist for at least 3-4 hours after the lights are turned off, and can disturb subsequent sleep. Avoiding these deleterious effects of light exposure prior to sleep on subsequent sleep would be beneficial to sleep quality and potentially health.
The investigators will compare the effects of two light sources, equated for visual stimulus (lux), on multiple non-visual responses to light. The investigators will compare a 90 lux exposure of a commercially available Compact Fluorescent Light (CFL) with a novel LED white light source that is depleted in the short-wavelength visible range (Biological Illumination LCC, FL). In a within-subject design, the investigators will test the hypotheses that exposure to a blue-depleted LED as compared to a CFL exposure at (1) 90 lux or (2) 50 lux will cause significantly:
- Less melatonin suppression between melatonin onset and bedtime;
- Less subjective and objective alerting responses before bedtime;
- Less disruption of nocturnal sleep structure and quality.
Tutkimuksen yleiskatsaus
Opintotyyppi
Ilmoittautuminen (Todellinen)
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Opiskelupaikat
-
-
Massachusetts
-
Boston, Massachusetts, Yhdysvallat, 02115
- Brigham and Women's Hospital
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
Hyväksyy terveitä vapaaehtoisia
Sukupuolet, jotka voivat opiskella
Kuvaus
Inclusion Criteria:
(i) Aged between 18-30 years to reduce the confounding effects of lens aging on the transmission of light to the retina;
(ii) Non-smoking for at least 6 months;
(iii) Healthy (no medical, psychiatric or sleep disorders);
(iv) No clinically significant deviations from normal in medical history, vital signs, physical examination, blood chemistry and hematology, urine chemistry and ECG;
(v) Women of childbearing potential must agree to use an acceptable method of birth control, and must have a negative urine pregnancy test;
(vi) Body mass index of > 18 or < 30 kg/m2;
(vii) No drugs or medication likely to affect sleep or alertness, as determined by the investigators;
(viii) Habitual caffeine consumption < 300mg per day on average;
(ix) Habitual alcohol consumption < 10 alcoholic units per week on average.
Exclusion Criteria:
(i) History of alcohol or substance abuse;
(ii) Positive result on drugs of abuse screening;
(iii) Current or past history of sleep disorders, including but not limited to obstructive sleep apnea, or any significant sleep complaint;
(iv) Psychiatric disorder;
(v) Recent acute or chronic medical disorder, including but not limited to hepatic impairment and severe chronic obstructive pulmonary disease;
(vi) Visual disorder, including but not limited to color blindness, or family history of glaucoma;
(vii) History of intolerance or hypersensitivity to melatonin or melatonin agonists;
(viii) Pregnancy or lactation;
(ix) Shift work;
(x) Transmeridian travel (2 or more time zones) in past 2 months;
(xi) Any other reason as determined by the Principal Investigator.
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Perustiede
- Jako: Satunnaistettu
- Inventiomalli: Tehtävätehtävä
- Naamiointi: Yksittäinen
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
---|---|
Active Comparator: Compact Fluorescent Light 90 lux
90 lux exposure of a commercially available Compact Fluorescent Light (CFL).
|
We will compare the effects of two light sources, equated for visual stimulus (lux), on multiple non-visual responses to light including melatonin suppression before bedtime.
We will compare a 90 lux exposure of a commercially available Compact Fluorescent Light (CFL) with a novel LED white light source that is depleted in the short-wavelength visible range (Biological Illumination LCC, FL).
|
Kokeellinen: Blue-depleted LED light 90 lux
90 lux exposure of a novel LED white light source that is depleted in the short-wavelength visible range (Biological Illumination LCC, FL).
|
We will compare the effects of two light sources, equated for visual stimulus (lux), on multiple non-visual responses to light including melatonin suppression before bedtime.
We will compare a 90 lux exposure of a commercially available Compact Fluorescent Light (CFL) with a novel LED white light source that is depleted in the short-wavelength visible range (Biological Illumination LCC, FL).
|
Active Comparator: Compact Fluorescent Light 50 lux
50 lux exposure of a commercially available Compact Fluorescent Light (CFL).
|
We will compare the effects of two light sources, equated for visual stimulus (lux), on multiple non-visual responses to light including melatonin suppression before bedtime.
We will compare a 90 lux exposure of a commercially available Compact Fluorescent Light (CFL) with a novel LED white light source that is depleted in the short-wavelength visible range (Biological Illumination LCC, FL).
|
Kokeellinen: Blue-depleted LED light 50 lux
50 lux exposure of a novel LED white light source that is depleted in the short-wavelength visible range (Biological Illumination LCC, FL).
|
We will compare the effects of two light sources, equated for visual stimulus (lux), on multiple non-visual responses to light including melatonin suppression before bedtime.
We will compare a 90 lux exposure of a commercially available Compact Fluorescent Light (CFL) with a novel LED white light source that is depleted in the short-wavelength visible range (Biological Illumination LCC, FL).
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
---|---|---|
Melatonin Suppression
Aikaikkuna: 6-h constant posture interval of the light exposure
|
Melatonin suppression is measured as the percentage of melatonin AUC relative to the AUC measured in dim light on the previous day.
AUC was calculated during the 6 h of light exposure and the corresponding 6-h interval 24 hours earlier.
Higher values indicate more light-induced melatonin suppression.
|
6-h constant posture interval of the light exposure
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
---|---|---|
Sleep Structure
Aikaikkuna: 8-h time in bed immediately following CFL/LED light exposure.
|
Sleep efficiency assessed by polysomnography.
Sleep efficiency refers to the percentage of time a person sleeps, in relation to the amount of time a person spends in bed trying to sleep.
The percentage is calculated by dividing the Total Sleep Time by the Total Time in Bed.
|
8-h time in bed immediately following CFL/LED light exposure.
|
Sleep Quality
Aikaikkuna: First morning after 8-h time in bed immediately following CFL/LED light exposure.
|
Self-reported sleep quality was assessed using a post sleep questionnaire.
Score on subjective scale range 1-7, higher scores indicate higher sleep quality.
|
First morning after 8-h time in bed immediately following CFL/LED light exposure.
|
Subjective Alerting Response
Aikaikkuna: 6-h constant posture interval of the light exposure.
|
Self-reported sleepiness measured during the light exposure using the Karolinska Sleepiness Scale (KSS).
Range of scores 1-9, higher score indicate higher subjective sleepiness.
Measures were taken hourly throughout the 6-hour constant posture interval of the light exposure and then averaged to calculate a single value per participant.
|
6-h constant posture interval of the light exposure.
|
Objective Alerting Response
Aikaikkuna: 6-h constant posture interval of the light exposure
|
Mean reaction time assessed using the 10-minute psychomotor vigilance test.
Higher numbers indicate slower reaction times indicating less alertness.
Measures were taken hourly throughout the 6-hour constant posture interval of the light exposure and then averaged to calculate a single value per participant.
|
6-h constant posture interval of the light exposure
|
Yhteistyökumppanit ja tutkijat
Sponsori
Yhteistyökumppanit
Tutkijat
- Päätutkija: Steven W Lockley, Ph.D., Brigham and Women's Hospital; Harvard Medical School
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus
Ensisijainen valmistuminen (Todellinen)
Opintojen valmistuminen (Todellinen)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Arvio)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Avainsanat
Muut tutkimustunnusnumerot
- 2011-P-002834
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Yhdysvalloissa valmistettu ja sieltä viety tuote
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .
Kliiniset tutkimukset Non-visual Photoreception
-
Kocaeli Derince Education and Research HospitalMustafa Kemal UniversityTuntematonVisual Analogue Score
-
Alanya Alaaddin Keykubat UniversityValmisSterilointi, tubal | Visual Analog Pain Scale
-
Korea University Anam HospitalKorea UniversityValmisKivun mittaus | Visual Analog Pain Scale
-
Turkish Ministry of Health, Kahramanmaras Provincial...Rekrytointi
-
University Hospital, Clermont-FerrandRekrytointiTyöperäinen stressi | Validointi | Visual Analogue ScaleRanska
-
Universitaire Ziekenhuizen KU LeuvenValmisVisual Pathway -taudit; NeurokuvantaminenBelgia
-
Ankara UniversityValmisKivun mittaus | Visual Analogue Pain ScaleTurkki
-
University Hospital, GrenobleValmisKuurous | Visual Analog Pain ScaleRanska
-
National Cancer Institute (NCI)Aktiivinen, ei rekrytointiMatala-asteinen glioma | Toistuva Visual Pathway Gliooma | Refractory Visual Pathway Gliooma | Toistuva lapsuuden pilosyyttinen astrosytooma | Toistuva neurofibromatoosi tyyppi 1 | Tulenkestävä neurofibromatoosi tyyppi 1Yhdysvallat
-
National Cancer Institute (NCI)ValmisTulenkestävä lymfooma | Tulenkestävä pahanlaatuinen kiinteä kasvain | Toistuva lymfooma | Toistuva pahanlaatuinen kiinteä kasvain | Toistuva primaarinen keskushermoston kasvain | Tulenkestävä primaarinen keskushermoston kasvain | Aivorungon kasvain | Käpyrauhasen alueen kasvain | Toistuva Visual Pathway Gliooma ja muut ehdotYhdysvallat
Kliiniset tutkimukset Visible light
-
RxSight, Inc.Valmis
-
Peking University People's HospitalRekrytointi
-
Zealand University HospitalGöteborg University; University of Copenhagen; Technical University of Denmark ja muut yhteistyökumppanitRekrytointi
-
RxSight, Inc.Valmis
-
RxSight, Inc.RekrytointiKaihi | AphakiaYhdysvallat
-
Zealand University HospitalUniversity of Copenhagen; Technical University of Denmark; OptoCeuticsValmis
-
Illumicure IncTuntematon
-
Medical University of ViennaValmisKausiluonteinen mielialahäiriöItävalta
-
Calhoun Vision, Inc.Valmis